In imaging analysis of central nervous system tumors, analyses that employ traditional radiomic analysis have been applied to combine imaging and molecular markers notably O6-methylguanine-DNA methyltransferase (MGMT) [74–77], IDH [74, 78–80], 1p19q [81, 82], H3K27M [83]. This evidence concerns the gene MGMT and central nervous system cancer.